Abdallah Yassine - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Abdallah Yassine

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Materials (Basel, Switzerland)|October 24, 2020

Mitigating Portland Cement CO<sub>2</sub> Emissions Using Alkali-Activated Materials: System Dynamics ModelMoncef L Nehdi, Abdallah Yassine

Current Research in Translational Medicine|March 21, 2026

Cladribine, low-dose cytarabine, and venetoclax in newly diagnosed and relapsed/refractory acute myeloid leukemia: A global perspectiveIman Abou Dalle, Abdallah Yassine, Ali Awada, et al.

Pharmaceutics|August 28, 2025

Melittin-Based Nanoparticles for Cancer Therapy: Mechanisms, Applications, and Future PerspectivesJoe Rizkallah, Nicole Charbel, Abdallah Yassine, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Materials (Basel, Switzerland)|October 24, 2020

Mitigating Portland Cement CO<sub>2</sub> Emissions Using Alkali-Activated Materials: System Dynamics ModelMoncef L Nehdi, Abdallah Yassine

Current Research in Translational Medicine|March 21, 2026

Cladribine, low-dose cytarabine, and venetoclax in newly diagnosed and relapsed/refractory acute myeloid leukemia: A global perspectiveIman Abou Dalle, Abdallah Yassine, Ali Awada, et al.

Pharmaceutics|August 28, 2025

Melittin-Based Nanoparticles for Cancer Therapy: Mechanisms, Applications, and Future PerspectivesJoe Rizkallah, Nicole Charbel, Abdallah Yassine, et al.

Pageof 1